Biotech company nears breakthrough in the resurrection of the extinct Tasmanian Tiger

A Dallas-based biotech company has nearly completed its reconstruction of the Tasmanian tiger just two years into its de-extinction project. The last known thylacine, commonly referred to as the Tasmanian tiger, died in captivity on Sept. 7, 1936. None have been spotted across Tasmania since, despite countless expeditions attempting to rediscover the tiger. Without the...

nypost.com

Read full article on: nypost.com

unread news